Development and evaluation of physical properties of a low-cost handheld device for airway clearance therapy

Authors

DOI:

https://doi.org/10.1590/1809-2950/18043126042019

Keywords:

Respiratory Therapy, Airway Management, Chest Wall Oscillation

Abstract

Several respiratory diseases are characterized by hypersecretion, requiring airway clearance therapy (ACT). Oral high-frequency oscillation (OHFO) devices are effective to enable daily ACT; however, they are still too expensive to become available for low-income patients. We sought to develop a low-cost device (OHFO-LC) and compare its physical properties with those OHFO commercially available (Shaker and Flutter). The OHFO-LC was developed from polyvinyl chloride material and one stainless steel sphere. Pressures and frequencies were measured at flows of 4, 6, 8, 10 and 15L/min. Pressures at the mouthpieces were measured by a transducer connected to a microcomputer. The oscillation frequencies were obtained from the graph of the pressure. The frequencies and pressures were compared among groups using one-way Anova and Tukey’s post hoc tests, p≤0.05. There were no differences among the frequencies of the three devices in all tested flows. The OHFO-LC device showed a higher positive expiratory pressure compared with the Shaker at all tested flows (4 L/min: 4.7±1.2 vs. 1.0±0.2 cmH2O; 6 L/min: 8.6±1.5 vs. 3.5±0.5 cmH2O; 8 L/min: 10.8±1.6 vs. 5.4±0.2 cmH2O; 10 L/min: 13.5±1.2 vs. 7.7±0.4 cmH2O; 15 L/min: 14.3±1.1 vs. 7.8±0.2 cmH2O; OHFO-LC vs. Shaker; p≤0.05) and at 10 and 15 L/min compared with Flutter (10 L/min: 13.5±1.2 vs. 7.5±1.2 cmH2O; 15 L/min: 14.3±1.1 vs. 8.2±1.2 cmH2O; OHFO-LC vs. Flutter, p≤0.05). The cost of the OHFO-LC device was much lower than both the Shaker and the Flutter. Our results showed that the OHFO-LC had physical properties with similar frequencies but higher pressures than other OHFO devices that are commercially available. Future studies are necessary to evaluate its clinical efficacy.

Downloads

Download data is not yet available.

Author Biography

  • Celso Ricardo Fernandes de Catvalho, Universidade de São Paulo, Faculdade de Medicina- FMUSP. SP. Brasil

    Physical Therapist and Physical Educator Master Degree and PhD in the University of São Paulo

References

Volsko TA. Airway clearance therapy: finding the evidence.

Respir Care. 2013;58(10):1669-78. doi: 10.4187/respcare.02590

dos Santos AP, Guimarães RC, de Carvalho EM, Gastaldi AC.

Mechanical behaviors of flutter VRP1, shaker and acapella devices.

Respir Care. 2013;58(2):298-304. doi: 10.4187/respcare.01685

Lee AL, Button BM, Tannenbaum EL. Airway-clearance

techniques in children and adolescents with chronic suppurative

lung disease and bronchiectasis. Front Pediatr. 2017;5:2. doi:

3389/fped.2017.00002

Flores JS, Teixeira FA, Rovedder PM, Ziegler B, Dalcin PT. Adherence

to airway clearance therapies by adult cystic fibrosis patients.

Respir Care. 2013;58(2):279-85. doi: 10.4187/respcare.01389

Myers TR. Positive expiratory pressure and oscillatory positive

expiratory pressure therapies. Respir Care [Internet]. 2007

[cited 2019 Sept 18];52(10):1308-26. Available from: https://

www.ncbi.nlm.nih.gov/pubmed/17894901

Lindemann H. The value of physical therapy with VRP 1-Desitin

(“Flutter”). Pneumologie [Internet]. 1992 [cited 2019 Sept

;46(12):626-30. Available from: https://www.ncbi.nlm.nih.

gov/pubmed/1494580

Souza MA, Pessan LA, Rodolfo Jr A. Nanocompósitos de poli

(cloreto de vinila) (PVC)/argilas organofílicas. Polímeros: Ciência

e Tecnologia [Internet]. 2006 [cited 2019 Sept 18];16(4):257-62.

Available from: http://www.scielo.br/pdf/po/v16n4/01.pdf

Volsko TA, DiFiore J, Chatburn RL. Performance comparison of

two oscillating positive expiratory pressure devices: Acapella

versus Flutter. Respir Care [Internet]. 2003 [cited 2019 Sept

;48(2):124-30. Available from: https://www.ncbi.nlm.nih.

gov/pubmed/12556253

de Lima LC, Duarte JB, Lépore Neto FP, Abe PT, Gastaldi AC.

Mechanical evaluation of a respiratory device. Med Eng Phys.

;27(2):181-7. doi: 10.1016/j.medengphy.2004.09.016

Jones AP, Rowe BH. WITHDRAWN: Bronchopulmonary

hygiene physical therapy for chronic obstructive pulmonary

disease and bronchiectasis. Cochrane Database Syst Rev.

;(7):CD000045. doi: 10.1002/14651858.CD000045

van der Schans CP. Airway clearance: assessment of techniques.

Paediatr Respir Rev 2002;3(2):110-4. https://doi.org/10.1016/

S1526-0550(02)00004-5

Hess DR. Secretion clearance techniques: absence of proof

or proof of absence? Respir Care 2002;47(7):757-8. Available

from: https://www.ncbi.nlm.nih.gov/pubmed/12088544

McCool FD, Rosen MJ. Nonpharmacologic airway clearance

therapies: ACCP evidence-based clinical practice guidelines.

Chest. 2006;129(1Suppl):250S–259S. doi: 10.1378/

chest.129.1_suppl.250S

Farbotko K, Wilson C, Watter P, MacDonald J. Change

in physiotherapy management of children with cystic

fibrosis in a large urban hospital. Physiother Theory Pract

;21(1):13-21. Available from: https://www.ncbi.nlm.nih.gov/

pubmed/16385940

Chatburn RL. High-frequency assisted airway clearance. Respir

Care 2007;52(9):1224-35. Available from: https://www.ncbi.

nlm.nih.gov/pubmed/17716388

Morrison L, Agnew J. Oscillating devices for airway clearance

in people with cystics fibrosis. Cochrane Database Syst Rev.

;(1):CD006842. doi: 10.1002/14651858.CD006842.pub2

Morrison L, Agnew J. Oscillating devices for airway clearance

in people with cystics fibrosis. Cochrane Database Syst Rev.

;(7):CD006842. doi: 10.1002/14651858.CD006842.pub3

Konstan MW, Stern RC, Doershuk CF. Efficacy of the flutter

device for airway mucus clearance in patients with cystic fibrosis.

J Pediatr. 1994;124:689-93. doi: 10.1016/s0022-3476(05)81356-3

Lubiński W, Targowski T, Frank-Piskorska A. Przydatność przyrzadu

flutter VRP1 w rehabilitacji chorych na przewlekłe choroby

układu oddechowego. Pol Merkuriusz Lek 2000;(43):37-40.

Available from: https://journals.indexcopernicus.com/search/

article?articleId=1060255

Elkins MR, Jones A, van der Schans C. Positive expiratory

pressure physiotherapy for airway clearance in people with

cystic fibrosis. Cochrane Database Syst Rev. 2006;(2):CD003147.

doi: 10.1002/14651858.CD003147.pub3

Thompson C, Harrison S, Ashley J, Day K, Smith D. Randomised

crossover study of the flutter device and the active cycle of

breathing technique in non-cystic fibrosis bronchiectasis.

Thorax. 2002;57(5):446-8. doi: 10.1136/thorax.57.5.446

Main E, Prasad A, Schans C. Conventional chest physiotherapy

compared to other airway clearance techniques for cystic

fibrosis. Cochrane Database Syst Rev. 2005;(1):CD002011.

doi:10.1002/14651858.CD002011.pub2

Downloads

Published

2019-08-07

Issue

Section

Original Research

How to Cite

Development and evaluation of physical properties of a low-cost handheld device for airway clearance therapy. (2019). Fisioterapia E Pesquisa, 26(4), 427-432. https://doi.org/10.1590/1809-2950/18043126042019